93 / 99
S
tevens
-J
ohnson
syndrome
and
toxic
epidermal
necrolysis
:
a
review
R
ev
A
ssoc
M
ed
B
ras
2016; 62(5):468-473
473
11. Biswal S, Sahoo SS. Paracetamol induced Stevens-Johnson syndrome--toxic
epidermal necrolysis overlap syndrome. Int J Dermatol. 2014; 53(8):1042-4.
12.
La Grenade L, Lee L, Weaver J, Bonnel R, Karwoski C, Governale L, et al.
Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal
necrolysis in association with selective COX-2 inhibitors. Drug Saf. 2005;
28(10):917-24.
13.
Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis: Part II.
Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and
treatment. J Am Acad Dermatol. 2013; 69(2):187.e1-16.
14.
Hamm RL. Drug-hypersensitivity syndrome: diagnosis and treatment. J Am
Coll Clin Wound Spec. 2011; 3(4):77-81.
15.
Fernando SL. The management of toxic epidermal necrolysis. Australas J
Dermatol. 2012; 53(3):165-71.
16. Cotliar J. Approach to the patient with a suspected drug eruption. Semin
Cutan Med Surg. 2007; 26(3):147-54.
17. Ghislain PD, Roujeau JC. Treatment of severe drug reactions: Stevens-
Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.
Dermatol Online J. 2002; 8(1):1087-108.
18.
Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein
P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J
Invest Dermatol. 2000; 115(2):149-53.